← back to search

Stefania Paolillo

Istituto Nazionale per le Ricerche Cardiovascolari · IT
Area of research
Cardiology and Cardiovascular Medicine · Complementary and alternative medicine
Research interest
Research interests include Cardiovascular Function and Risk Factors, Heart Failure Treatment and Management, Cardiovascular and exercise physiology, and Cardiac Imaging and Diagnostics.
h-index
41
citations
5,896
works
307
NIH funding
primary concept
Medicine
email

Recent publications

Implementation of Guideline-Directed Medical Therapy in Patients with Heart Failure with Reduced Ejection Fraction (OpTIMa-HF Registry)
ESC Heart Failure 2025cited by 13position: firstdoi
Adherence to Guideline-Directed Medical Treatments in Heart Failure. A Scientific Statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Cardiovascular Pharmacotherapy
European Journal of Heart Failure 2025cited by 9position: middledoi
Biomarkers for Congestion in Heart Failure: State-of-the-art and Future Directions
Cardiac Failure Review 2025cited by 9position: contributordoi
Biomarkers for Congestion in Heart Failure: State-of-the-art and Future Directions
Cardiac failure review 2025cited by 8position: middledoi
Growth Hormone Replacement Therapy in Heart Failure With Reduced Ejection Fraction
JACC Heart Failure 2025cited by 8position: middledoi
Non cardiovascular comorbidities in Heart Failure. An updated position paper from the Heart Failure Working Group of the Italian Society of Cardiology (SIC)
European Journal of Internal Medicine 2025cited by 5position: contributordoi
Efficacy of Mediterranean diet for the prevention of cardiovascular disease in patients: A systematic review and meta-analysis featured in the Italian National Guidelines “La Dieta Mediterranea”
Nutrition 2025cited by 1position: middledoi
Effectiveness of Mediterranean diet for the primary prevention of cardiovascular diseases: A systematic review and meta-analysis featured in the Italian National Guidelines “La Dieta Mediterranea”
Nutrition 2025cited by 0position: middledoi
Novel potassium binders to optimize RAASi therapy in heart failure: A systematic review and meta-analysis.
2024cited by 8position: contributordoi
Subclinical hypothyroidism predicts outcome in heart failure: insights from the T.O.S.CA. registry
Internal and Emergency Medicine 2024cited by 3position: middledoi
Guideline-directed medical therapy patterns in heart failure with reduced ejection fraction: the OPTIMA-HF registry
European Heart Journal 2024cited by 1position: firstdoi
Correction: Subclinical hypothyroidism predicts outcome in heart failure: insights from the T.O.S.CA. registry
Internal and Emergency Medicine 2024cited by 0position: middledoi
Right heart failure in left heart disease: imaging, functional, and biochemical aspects of right ventricular dysfunction.
2023cited by 25position: contributordoi
Quality of life in heart failure. The heart of the matter. A scientific statement of the Heart Failure Association and the European Association of Preventive Cardiology of the European Society of Cardiology
European Journal of Preventive Cardiology 2023cited by 10position: middledoi
Left atrium decompression devices across the spectrum of ejection fraction in heart failure: an updated systematic review and meta-regression analysis.
2023cited by 1position: contributordoi
Progressive right ventricular dysfunction and exercise impairment in patients with heart failure and diabetes mellitus: insights from the T.O.S.CA. Registry
Cardiovascular Diabetology 2022cited by 22position: middledoi
Renin-angiotensin-aldosterone system inhibition in patients affected by heart failure: efficacy, mechanistic effects and practical use of sacubitril/valsartan. Position Paper of the Italian Society of Cardiology
European Journal of Internal Medicine 2022cited by 21position: middledoi
Renin-angiotensin-aldosterone system inhibition in patients affected by heart failure: efficacy, mechanistic effects and practical use of sacubitril/valsartan. Position Paper of the Italian Society of Cardiology.
2022cited by 17position: contributordoi
Insulin-like growth factor-1 (IGF-1) as predictor of cardiovascular mortality in heart failure patients: data from the T.O.S.CA. registry
Internal and Emergency Medicine 2022cited by 14position: middledoi
Testosterone Deficiency Independently Predicts Mortality in Women with HFrEF: Insights from the T.O.S.CA. Registry
ESC Heart Failure 2022cited by 9position: middledoi
Massive Thrombosis of Mitral Bioprosthesis Due to SARS-CoV-2 Infection.
2022cited by 1position: contributordoi
Multiple hormonal and metabolic deficiency syndrome predicts outcome in heart failure: the T.O.S.CA. Registry
European Journal of Preventive Cardiology 2021cited by 56position: middledoi
Gender and Age Normalization and Ventilation Efficiency During Exercise in Heart Failure with Reduced Ejection Fraction
ESC Heart Failure 2020cited by 44position: middledoi
Cardiac Implantable Electronic Devices with a Defibrillator Component and All-Cause Mortality in Left Ventricular Assist Device Carriers: Results from the PCHF-VAD Registry
European Journal of Heart Failure 2019cited by 40position: middledoi
Exercise Oscillatory Ventilation and Prognosis in Heart Failure Patients with Reduced and Mid-Range Ejection Fraction
European Journal of Heart Failure 2019cited by 30position: middledoi
Comprehensive effects of left ventricular assist device speed changes on alveolar gas exchange, sleep ventilatory pattern, and exercise performance
The Journal of Heart and Lung Transplantation 2018cited by 46position: middledoi
Non-invasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients
European Heart Journal - Cardiovascular Imaging 2017cited by 77position: middledoi
Noninvasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients
Journal of Hypertension 2017cited by 61position: middledoi
Lvad pump speed increase is associated with increased peak exercise cardiac output and vo2, postponed anaerobic threshold and improved ventilatory efficiency
International Journal of Cardiology 2016cited by 50position: middledoi
Benefits of Statins in Elderly Subjects Without Established Cardiovascular Disease
Journal of the American College of Cardiology 2013cited by 229position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Pasquale Perrone Filardi · University of Naples Federico II12 papers (2013–2025) · 7 papers (2022–2025)Piergiuseppe Agostoni · University of Milan4 papers (2016–2023)Savina Nodari · Brescia University3 papers (2022–2025)Andrea Salzano · University of Leicester3 papers (2024–2025)Roberta D’Assante · University Hospital Heidelberg3 papers (2024–2025)Alberto M. Marra · Sapienza University of Rome3 papers (2024–2025) · 3 papers (2024–2025)Eduardo Bossone · University of Bergen3 papers (2024–2025) · 2 papers (2017–2017)Armando Ferrera · Twitter (United States)2 papers (2025–2025)Antonio Cannatà · British Heart Foundation2 papers (2025–2025)Roland E. Schmieder · Bayer (Germany)2 papers (2017–2017)Giuseppe Limongelli · Fondazione Toscana Gabriele Monasterio2 papers (2024–2024) · 2 papers (2016–2018) · 2 papers (2025–2025)Thomas Kahan · Danderyds sjukhus2 papers (2017–2017)Erwan Donal · Pfizer (France)2 papers (2017–2017)Marco Metra · Mylan (South Africa)2 papers (2022–2023)Massimo Volpe · IRCCS Ospedale San Raffaele2 papers (2022–2025)